Elixinol Granted CBD Processor Research Partner Authorization by New York State
DENVER, May 15, 2019 (GLOBE NEWSWIRE) -- Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that it has been officially granted a CBD Processor Research Partner Authorization by the New York State Department of Agriculture and Markets. The Department promotes New York agriculture and its high-quality and diverse products, fosters agricultural environmental stewardship, and safeguards the State’s food supply, land, and livestock to ensure the viability and growth of New York’s agriculture industries.
“Elixinol strives to ensure it operates within strict regulatory compliance on the state level,” said Chris Husong, VP of Marketing and Communications at Elixinol. “All of our products come with the highly coveted U.S. Hemp Authority stamp of approval, and we are very proud to be authorized to produce our CBD products in New York, which state hemp program requires exemplary standards for safety and quality assurance.”
New York is cultivating the industrial hemp market and supporting new opportunities to grow the crop and supports one of the nation’s most robust hemp agricultural pilot programs, particularly as it relates to the promotion of safe, quality assured hemp extract and hemp-derived CBD products that are manufactured, tested, and labeled in strict accordance with the rigorous standards of all FDA regulations related to dietary supplements. After a successful first exploratory year allowing the processing and manufacture of hemp extract and hemp-derived CBD products under its program, the Department re-opened the application period for CBD Processor Research Partners for a short window of time at the end of 2018 from December 4 through December 28, and Elixinol submitted its application to join the Empire State during that time.
“We are excited to continue to scale our production and efficiency, and support the state of New York’s economy while doing so,” said Gabriel Ettenson, President and Co-Founder of Elixinol. “As a life-long New Yorker myself, and as someone who built my first business in the State, I know the CBD industry will continue to benefit New York greatly.”
“We are proud to distribute hemp CBD products in a state that brings over 100,000 manufacturing jobs, helping to drive the New York State economy,” said Ron Dufficy, CFO of Elixinol Global. “It is an honor to be officially granted a CBD Processor Research Partner Authorization by the New York Department of Agriculture and Markets.”
For more information on Elixinol and its products, visit Elixinol.com.
About Elixinol: Colorado-based Elixinol, co-founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and extracting premium-quality hemp, Elixinol is one of the few CBD hemp extract brands with complete seed-to-sale control over its products. Elixinol also conducts rigorous third-party laboratory testing and quality control. Elixinol distributes hemp-derived CBD products in 40 countries globally including North and South America, throughout Europe, Asia, and the Pacific Region under its own label as well as bulk CBD and wholesale CBD. Elixinol’s parent company EXL ( elixinolglobal.com ) is publicly traded on the Australian Securities Exchange and on the U.S. OTC (ASX:EXL, OTCQX: ELLXF). More information available at Elixinol.com.
Media Contact:Blythe TokarMULTIPLY202-292-4573 firstname.lastname@example.org
Chris HusongElixinol+1 844-804-3504 ext 420 email@example.com